US Patent Issued to TA Pharma on Jan. 13 for "Compositions for the treatment of chronic vulval and perineal pain and symptoms and conditions associated therewith" (Australian Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,403, issued on Jan. 13, was assigned to TA Pharma Pty Ltd. (Castlecrag, Australia).

"Compositions for the treatment of chronic vulval and perineal pain and symptoms and conditions associated therewith" was invented by Thierry Vancaillie (Castlecrag, Australia) and Alan Hewitt (Wrexham, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provides herein are compositions for the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith, comprising an estrogen, optionally estriol, and a tricyclic antidepressant, optionally amitriptyline, formulated for topical, transdermal or transmucosal administration. Also...